Clinical Research Directory
Browse clinical research sites, groups, and studies.
Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment
Sponsor: Hellenic Institute for the Study of Sepsis
Summary
Investigators aim is to conduct an RCT to study the effect of adjunct metformin treatment to insulin monotherapy in patients with type 1 diabetes, targeting the intestinal incretin secretion. The patients will be randomly allocated to metformin or placebo treatment for 4 months
Official title: Gut-derived Incretin Hormones in the Pathophysiology of Type 1 Diabetes Mellitus; Effect of Metformin Treatment
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
0
Start Date
2019-11-29
Completion Date
2024-12-31
Last Updated
2026-11-03
Healthy Volunteers
No
Conditions
Interventions
Metformin
Participants will be randomized to metformin 2000 mg
Placebo
Participants will be randomized to placebo